Turkish scientists will soon begin clinical trials of an intranasal coronavirus vaccine; they plan to use it this year. This was announced on Tuesday, March 30, by Turkish Industry Minister Mustafa Varank, Haberler writes.
According to the minister, the drug in the form of a nasal spray has successfully passed preclinical testing. Varnak said that the first phase of clinical trials of such a vaccine “will start soon.”
After completing all clinical trials, Turkey plans to start using the intranasal vaccine in 2021, he added.
As scientists expect, the vaccine in the form of a nasal spray will be more effective in fighting coronavirus infection.
In November last year, the first phase of clinical trials of its own coronavirus vaccine began in Turkey.
As Turkish President Recep Tayyip Erdogan reported, its own vaccine may be ready in the spring of 2021.
Large-scale vaccination of the population against coronavirus in Turkey began on January 14. In particular, the vaccine is done with CoronaVac, which was produced by the Chinese company Sinovac Biotech.
According to the Worldometer portal, as of March 30, more than 3.2 million cases of COVID-19 were recorded in Turkey, 31.2 thousand people died, 2.9 million recovered.